HI
TMO icon

Horizon Investments’s Thermo Fisher Scientific TMO Stock Holding History

Horizon Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.89M Buy
16,060
+533
+3% +$289K 0.09% 198
2025
Q4 		$9M Buy
15,527
+209
+1% +$118K 0.11% 149
2025
Q3 		$7.43M Buy
15,318
+2,972
+24% +$1.38M 0.1% 175
2025
Q2 		$5.01M Buy
12,346
+4,455
+56% +$1.86M 0.08% 193
2025
Q1 		$3.93M Buy
7,891
+222
+3% +$120K 0.12% 110
2024
Q4 		$3.99M Buy
7,669
+184
+2% +$101K 0.11% 102
2024
Q3 		$4.63M Buy
7,485
+2,872
+62% +$1.7M 0.12% 80
2024
Q2 		$2.55M Buy
4,613
+32
+0.7% +$18.3K 0.07% 133
2024
Q1 		$2.66M Buy
4,581
+89
+2% +$49.9K 0.07% 132
2023
Q4 		$2.38M Buy
4,492
+686
+18% +$332K 0.07% 130
2023
Q3 		$1.93M Buy
3,806
+119
+3% +$63.4K 0.06% 123
2023
Q2 		$1.92M Buy
3,687
+375
+11% +$202K 0.06% 125
2023
Q1 		$1.91M Sell
3,312
-1,766
-35% -$995K 0.06% 118
2022
Q4 		$2.8M Buy
5,078
+2,560
+102% +$1.36M 0.08% 114
2022
Q3 		$1.28M Sell
2,518
-1,946
-44% -$1.09M 0.04% 167
2022
Q2 		$2.42M Sell
4,464
-4,431
-50% -$2.44M 0.08% 98
2022
Q1 		$5.25M Buy
8,895
+517
+6% +$297K 0.15% 75
2021
Q4 		$5.59M Buy
8,378
+2,733
+48% +$1.71M 0.17% 70
2021
Q3 		$3.23M Sell
5,645
-1,739
-24% -$954K 0.08% 108
2021
Q2 		$3.73M Sell
7,384
-2,929
-28% -$1.38M 0.11% 92
2021
Q1 		$4.71M Buy
+10,313
New +$4.92M 0.17% 56
2020
Q4 		– Sell
-4,589
Closed -$2.03M – 371
2020
Q3 		$2.03M Sell
4,589
-13,577
-75% -$5.61M 0.07% 124
2020
Q2 		$6.58M Buy
18,166
+13,939
+330% +$4.67M 0.16% 69
2020
Q1 		$1.2M Buy
4,227
+959
+29% +$302K 0.06% 118
2019
Q4 		$1.06M Buy
3,268
+1,155
+55% +$350K 0.05% 161
2019
Q3 		$615K Sell
2,113
-1,285
-38% -$368K 0.02% 151
2019
Q2 		$998K Buy
3,398
+1,873
+123% +$516K 0.03% 131
2019
Q1 		$417K Buy
+1,525
New +$380K 0.01% 221

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Horizon Investments's TMO Position: Q1 2026 in Review

Horizon Investments increased its Thermo Fisher Scientific (TMO) stake by 3.4% in Q1 2026, buying an estimated $289K and bringing the position to 16,060 shares worth $7.89M. The position accounts for 0.09% of the portfolio, ranked #198.

Horizon Investments first reported a position in TMO in Q1 2019 and has held it in 28 quarters since. The position peaked at $9M in Q4 2025. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Horizon Investments held 16,060 shares of Thermo Fisher Scientific worth $7.89M as of Q1 2026.
  • Horizon Investments bought 533 Thermo Fisher Scientific shares in Q1 2026, an estimated $289K.
  • Thermo Fisher Scientific made up 0.09% of Horizon Investments's portfolio in Q1 2026, its #198 holding.
  • Horizon Investments first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 28 quarters since.
  • Horizon Investments's Thermo Fisher Scientific position peaked at $9M in Q4 2025.
  • 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.